Lowered B-Type Natriuretic Peptide in Response to Levosimendan or Dobutamine Treatment Is Associated With Improved Survival in Patients With Severe Acutely Decompensated Heart Failure
- 23 June 2009
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 53 (25), 2343-2348
- https://doi.org/10.1016/j.jacc.2009.02.058
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Natriuretic PeptidesJournal of the American College of Cardiology, 2007
- The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT‐proBNP and cardiac troponin‐TEuropean Journal of Heart Failure, 2007
- N-Terminal Pro–B-Type Natriuretic Peptide Testing Improves the Management of Patients With Suspected Acute Heart FailureCirculation, 2007
- Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart FailureJAMA, 2007
- The Biologic Variability of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide in Stable Heart Failure PatientsJournal of Cardiac Failure, 2007
- Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failureJournal of the American College of Cardiology, 2004
- Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute DyspneaThe New England Journal of Medicine, 2004
- Biological variation for N-Terminal Pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failureThe American Journal of Cardiology, 2003
- Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspneaJournal of the American College of Cardiology, 2002
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureThe New England Journal of Medicine, 2002